PIEZOBITE Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for PIEZOBITE with the United States Patent and Trademark Office. The USPTO has given the PIEZOBITE trademark a serial number of 98417015. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 25, 2024. The PIEZOBITE trademark is filed in the Pharmaceutical Products category with the following description:

Dental bite registration materials
piezobite

General Information


Serial Number98417015
Word MarkPIEZOBITE
Filing DateThursday, February 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDental bite registration materials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code005
First Use Anywhere DateWednesday, February 21, 2024
First Use In Commerce DateWednesday, February 21, 2024

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressFremont, CA 94538

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024NEW APPLICATION ENTERED
Thursday, February 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Wednesday, September 25, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024NON-FINAL ACTION WRITTEN